Senores Pharmaceuticals Limited reports a change in its board or management
In short
Senores Pharmaceuticals Limited informed the Exchange that it has re-appointed Mr. Chetan Bipinchandra Shah as Whole Time Director with effect from November 10, 2026. In simple terms, the company is keeping the same executive in a key leadership role for another term, so there is no change in who runs that part of the business. The appointment takes effect on November 10, 2026.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.